SCHEMBL7063529

SCHEMBL7063529

CCCNC(=O)NCC[C@H](O)C(Cc1cc(F)cc(F)c1)NC(=O)c1cc(C)cc(C(=O)N(CCC)CCC)c1

nearest known ligand 0.66

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.66
BACE2 Q9Y5Z0 5/20 0.66
CTSD P07339 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5376142 1.00 BACE1 (0.66) BACE1BACE2CTSD
SCHEMBL6807520 1.00 BACE1 (0.66) BACE1BACE2CTSD
SCHEMBL5376143 1.00 BACE1 (0.66) BACE1BACE2CTSD
SCHEMBL5367912 0.90 BACE1 (0.65) BACE1BACE2CTSD
SCHEMBL5367907 0.90 BACE1 (0.65) BACE1BACE2CTSD
SCHEMBL5374149 0.90 BACE1 (0.65) BACE1BACE2CTSD
SCHEMBL5372551 0.90 BACE1 (0.64) BACE1BACE2CTSD
SCHEMBL5375434 0.90 BACE1 (0.64) BACE1BACE2CTSD
SCHEMBL5365694 0.89 BACE1 (0.65) BACE1BACE2CTSD
SCHEMBL6802169 0.89 BACE1 (0.65) BACE1BACE2CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004058686-A1 HYDROXYPROPYL AMIDES FOR THE TREATMENT OF ALZHEIMER’S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2004-07-15 WO claimed